The lungs are affected by illnesses including asthma, chronic obstructive pulmonary
disease, and infections such as influenza and SARS-CoV-2. Physiologically relevant models …

Current guidelines recommend inhalation therapy as the preferred route of drug
administration for treating patients with chronic obstructive pulmonary disease (COPD) …

This review is the summary of a workshop on small airways disease, which took place in
Porquerolles, France in November 2011. The purpose of this workshop was to review the …

Chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease
(COPD), represent a major social and economic burden for worldwide health systems …

Pulmonary abnormalities, dysfunction or hyper-reactivity occurs in association with
inflammatory bowel disease (IBD) more frequently than previously recognized. Emerging …

Inhalation therapy of lipid-based carriers has great potential in direct target towards the root
of respiratory diseases, which make them superior over other drug deliveries. With the …

Evidence that enables us to identify, assess, and access the small airways in asthma and
chronic obstructive pulmonary disease (COPD) has led INTERASMA (Global Asthma …

Background: Low lung function is known to predict mortality in the general population, but
the prognostic significance of emphysema on computed tomography (CT) in persons without …

Background Small airway remodeling is the cardinal feature underlying chronic airway
diseases. There is no modality which identifies small airway pathological changes, which is …

Current pharmacological treatments for chronic obstructive pulmonary disease (COPD) are
mostly limited to inhaled bronchodilators and corticosteroids. Azithromycin can contribute to …